to determine how hmg stimulation affected ovarian androgen production during such therapy , plasma androstenedione ( a ) and testosterone ( t ) levels were measured at the beginning and end of hmg therapy in 5 patients with anovulatory hypogonadotropism ( group 1 ) and 15 patients with anovulatory polycystic ovary syndrome ( group 2 ) .
C0039601
testosterone
C0020619
hypogonadotropism